Munogenics::BIOcommittee

A cancer resistant leukocyte "vaccine" against solid cancers by training innate cancer immunity.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Employees 4
  • Website munogenics.com

Company Summary

We have a new and innovative way to treat most types of cancer utilizing non-toxic cancer killing white blood cells.

Team

  • Beau Raines
    CEO

  • Robert Ainbinder
    CFO

  • Steffini Stalos
    Medical Director

  • Amy Hicks
    Chief Scientific Officer

  • Mark Willingham
    Scientific Advisor

  • Beau Raines

Advisors

  • John McDuff
    Lawyer
    Unconfirmed
    Diedre Ainbinder
    Accountant
    Unconfirmed

Previous Investors

  • None
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free